Description:

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521) NCT00492856 Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DB0EF4-F2F0-5AA4-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DB0EF4-F2F0-5AA4-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 6/9/15
Uploaded on:

June 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521) NCT00492856

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521)
    1. No Instruction available.
Header
Participating Group Name
Post-Consolidation Eligibility Assessment
Was an RT-PCR result obtained from the marrow specimen
Was an RT-PCR result obtained from the blood specimen
Performance Status
Comments

Similar models